Coronary atherosclerotic heart disease
Conditions
Interventions
Normal Group:no
MACE Group:no
Sponsors
The Affiliated Taian City Central Hospital of Qingdao University
Eligibility
Sex/Gender
All
Age
18 Years to 90 Years
Inclusion criteria
Inclusion criteria: 1) Age > 18 years; 2) Meet the diagnostic criteria for coronary artery disease in the Diagnostic and Therapeutic Guidelines for Stable CHD; 3) CYP2C19 normal metabolic; 4) First PCI treatment; 5) Receiving oral clopidogrel (75 mg orally once a day) combined with aspirin (100 mg orally once a day) for antiplatelet treatment for 12 months, and including patients with MACE during this period; 6) Having complete case data and being followed up until the end event.
Exclusion criteria
Exclusion criteria: 1) malignant tumors; 2) Contraindications to antiplatelet therapy; 3) Bleeding disorders; 4) Severe organ insufficiency; 5) Pregnancy or lactation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ABCB1 genotype;fasting blood glucose;MACE; | — |
Secondary
| Measure | Time frame |
|---|---|
| gender;age;history of smoking;history of drinking ;Homocysteine concentration; | — |
Countries
China
Contacts
Public Contactzhoubo
The Affiliated Taian City Central Hospital of Qingdao University
Outcome results
None listed